Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
SCOUT-HCM demonstrated the superiority of Camzyos on the primary endpoint and multiple secondary endpoints The overall safety results in this study were consistent... Read more.
Genesco Reports Comparable Sales
–Fourth Quarter-to-Date Comparable Sales Increased 9% Year-Over-Year– –Company Now Expects Increased Fiscal 2026 Adjusted EPS to be at Least $1.301—... Read more.
Study Shows NuScale Power Technology Can Support Profitable, Reliable Power for Chemical Plants
Study validates an exciting path for powering commercial chemical plants Findings show that pairing NuScale’s advanced nuclear technology with a heat augmentation... Read more.
US Foods Reaffirms Fiscal Year 2025 Guidance
Company to Participate at the 2026 ICR Conference ROSEMONT, Ill.–(BUSINESS WIRE)–US Foods Holding Corp. (NYSE: USFD) announced today that it is reaffirming... Read more.
J.Jill, Inc. Raises Fourth Quarter Guidance Ahead of the 28th Annual ICR Conference
QUINCY, Mass.–(BUSINESS WIRE)–J.Jill, Inc. (NYSE:JILL) today raised its fourth quarter fiscal 2025 guidance in advance of its fireside chat and investor... Read more.
ShareBuilder 401k Empowers the Self-Employed With Free Solo 401(k) Setup to Start the New Year
Leading digital provider waives setup costs for “companies of one” from January 12 through February 4 to help solopreneurs maximize tax savings for 2025 and... Read more.
CitiTrends Announces 2025 Holiday Sales Results
Total Holiday Sales for the nine-week period ending January 3, 2026 of $191.2 million, an increase of 9.6% to last year Comparable store sales growth of 9.3%; Two-year... Read more.
Spire Global Successfully Launches 9 Satellites on SpaceX’s Twilight Mission
Launch includes next-generation hyperspectral microwave sounder to advance global weather forecasting VIENNA, Va.–(BUSINESS WIRE)–Spire Global, Inc.... Read more.
Zura Bio Reports Business Updates and Outlook for 2026
2026 begins as a transformative year for Zura with potential clinical validation of tibulizumab as a groundbreaking therapy in hidradenitis suppurativa (HS) Expanded... Read more.
lululemon athletica inc. Updates Revenue and Earnings Expectations for the Fourth Quarter Ahead of the ICR Conference
VANCOUVER, British Columbia–(BUSINESS WIRE)–lululemon athletica inc. (NASDAQ:LULU) today announced that the Company now expects net revenue and diluted... Read more.